Bepotastine Besilate
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Comparative Efficacy and Safety of Topical Bepotastine Besilate 1.5% Versus Sodium Cromoglycate 4% in Chronic Allergic Conjunctivitis: A Prospective Study.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: June 10, 2026
Comparative Effectiveness and Safety of Second-Generation Antihistamines Treatments for Chronic Urticaria: A Network Meta-Analysis.
Journal: International archives of allergy and immunology
Published: June 03, 2025
Treatment of allergic rhinitis and allergic conjunctivitis.
Journal: The Medical letter on drugs and therapeutics
Published: March 28, 2025
The Efficacy of Bepotastine Besilate Compared With Hydroxyzine Pamoate for Preventing Infusion Reactions to the First Dose of Rituximab in Patients With Non-Hodgkin Lymphoma: Protocol for a Phase II, Double-Blind, Multicenter Randomized Trial.
Journal: JMIR research protocols
Published: November 27, 2023
Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: August 30, 2023
In brief: OTC alcaftadine (Lastacaft Once Daily Relief) for allergic conjunctivitis.
Journal: The Medical letter on drugs and therapeutics
Published: May 10, 2022
An Investigator-Blind Randomized Controlled Trial Comparing Effectiveness, Safety of Levocetirizine and Bepotastine in Chronic Urticaria.
Journal: Indian journal of dermatology
Published: January 24, 2022
Efficacy and safety of rupatadine fumarate in the treatment of perennial allergic rhinitis: A multicenter, double-blinded, randomized, placebo-controlled, bridging study in Koreans.
Journal: Asian Pacific journal of allergy and immunology
Published: July 11, 2021
Drugs for allergic rhinitis and allergic conjunctivitis.
Journal: The Medical letter on drugs and therapeutics
Published: April 13, 2021
To evaluate the efficacy and safety of olopatadine 0.1% ophthalmic solution and bepotastine 1.5% ophthalmic solution in patients with vernal keratoconjunctivitis in a tertiary care hospital.
Journal: Indian journal of pharmacology
Published: March 05, 2021
Comparative study on the efficacy and safety of bepotastine besilate versus levocetirizine in chronic spontaneous urticaria: A randomised, open-label, parallel study.
Journal: Indian journal of dermatology, venereology and leprology
Published: March 01, 2021
Last Updated: 06/30/2026